In the news: FTZ speculation, regulatory disputes and life sciences challenges
September 26, 2013 | BY
clpstaff &clp articlesShanghai's Free Trade Zone remains the focus of speculation, while a solution has been proposed for the standoff between US and Chinese regulators. Life sciences companies are having an increasingly tough time protecting their IP in China.
Share:
Shanghai FTZ – speculation continues
This week theSouth China Morning Post reported that internet users in the Shanghai Free Trade Zone would be able to access websites blocked in the rest of China, such as